Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors from the central nervous system, conolidine modulates alternate molecular targets. A Science Advances analyze identified that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://zanderlgksv.blogzag.com/81254527/the-ultimate-guide-to-alternative-natural-pain-relief-to-replace-traditional-painkillers